BioMarin Pharmaceutical
BMRN
$80.40
Share price
0.94%
Change (1 day)
-15.53%
Change (1 year)
Categories
BioMarin Pharmaceutical (BMRN) - Total assets
Total assets on the balance sheet as of March 2024 : $6.87 B
According to BioMarin Pharmaceutical's latest financial reports the company's total assets are $6.87 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
BioMarin Pharmaceutical - Total assets on balance sheet (from 2001 to 2024)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $6.84 B | 7.32% |
| 2022-12-31 | $6.37 B | 6.17% |
| 2021-12-31 | $6.00 B | 2.68% |
| 2020-12-31 | $5.84 B | 24.69% |
| 2019-12-31 | $4.69 B | 5.94% |
| 2018-12-31 | $4.42 B | -4.45% |
| 2017-12-31 | $4.63 B | 15.15% |
| 2016-12-31 | $4.02 B | 7.89% |
| 2015-12-31 | $3.72 B | 50.66% |
| 2014-12-31 | $2.47 B | 10.31% |
| 2013-12-31 | $2.24 B | 43.08% |
| 2012-12-31 | $1.56 B | 20.11% |
| 2011-12-31 | $1.30 B | 3.41% |
| 2010-12-31 | $1.26 B | 37.67% |
| 2009-12-31 | $0.91 B | 1.15% |
| 2008-12-31 | $0.90 B | 11.21% |
| 2007-12-31 | $0.81 B | 75.92% |
| 2006-12-31 | $0.46 B | 137.29% |
| 2005-12-31 | $0.19 B | -16.17% |
| 2004-12-31 | $0.23 B | -9.12% |
| 2003-12-31 | $0.25 B | 131.74% |
| 2002-12-31 | $0.11 B | -35.62% |
| 2001-12-31 | $0.17 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $139.81 B | 1,934.38% | 🇫🇷 France |
 Ultragenyx RARE | $1.49 B | -78.31% | 🇺🇸 USA |
 Sangamo Therapeutics
SGMO | $0.16 B | -97.59% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | $0.20 B | -97.01% | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | $0.77 B | -88.68% | 🇺🇸 USA |
 Catalyst Pharmaceuticals CPRX | $0.47 B | -93.16% | 🇺🇸 USA |